Transposon Therapeutics

Business Data, Corporate Office and Headquarter Address

About

Transposon Therapeutics is Drug Discovery in United States that focus on operator business. Founded in 2019. They cover business area such as operator, clinical-stage startup company, novel drug, neurodegenerative disease, aging.

Business Type

Drug Discovery

Country

United States

Founded

2019
( 5 years old in 2024 )

Company Focus

Operator

Website

-

Corporate Office and Headquarter Office address:

285 Riverside Avenue
Suite 250
Westport, CT 06880
United States

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

operatorclinical-stage startup companynovel drugneurodegenerative diseaseaging

* We use standard office opening hours in near Transposon Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

Transposon Therapeutics Frequently Asked Questions

What or who is Transposon Therapeutics?

Transposon Therapeutics is Drug Discovery business from United States that founded in 2019 (5 years old in 2024), Transposon Therapeutics business is focusing on Operator.

Where is Transposon Therapeutics headquarter and corporate office address?

Transposon Therapeutics headquarter office and corporate office address is located in 285 Riverside Avenue Suite 250 Westport, CT 06880 United States.

Where is Transposon Therapeutics country origins?

Transposon Therapeutics was founded in United States.

What is Operator business focus on?

In 2024, Transposon Therapeutics is currently focus on operator sector.

Operator Business Interest from Google Trend

Above is snippet of Google Trends for "operator" term, if you have problem loading the snippet, please visit here: Google Trend.

Disclaimer: This website is not affiliated with Transposon Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.